麻豆影视

Skip to main content

The U.S. Supreme Court wrestles with OxyContin maker's bankruptcy deal, with billions of dollars at stake

Signs in the shape of grave headstones, with information on people who died from using OxyContin, line a security fence outside the Supreme Court Monday, Dec. 4, 2023, in Washington.The Supreme Court is wrestling with a nationwide settlement with OxyContin maker Purdue Pharma that would shield members of the Sackler family who own the company from civil lawsuits over the toll of opioids. (AP Photo/Stephanie Scarbrough) Signs in the shape of grave headstones, with information on people who died from using OxyContin, line a security fence outside the Supreme Court Monday, Dec. 4, 2023, in Washington.The Supreme Court is wrestling with a nationwide settlement with OxyContin maker Purdue Pharma that would shield members of the Sackler family who own the company from civil lawsuits over the toll of opioids. (AP Photo/Stephanie Scarbrough)
Share
WASHINGTON -

The U.S. Supreme Court on Monday wrestled with a nationwide settlement with OxyContin maker Purdue Pharma that would shield members of the Sackler family who own the company from civil lawsuits over the toll of opioids.

The justices seemed by turns relucant to break up an exhaustively negotiated agreement, but also leery of somehow rewarding the Sacklers.

The agreement hammered out with state and local governments and victims would provide billions of dollars to combat the opioid epidemic. The Sacklers would contribute up to US$6 billion and give up ownership of the company, but retain billions more. The company would emerge from bankruptcy as a different entity, with its profits used for treatment and prevention.

The high court put the settlement on hold during the summer, in response to objections from the Biden administration.

Justice Elena Kagan seemed to sum up the questions that were nagging at some of the justices.

"It seems as though the federal government is standing in the way of that as against the huge, huge, huge majority of claimants," Kagan said.

But later, she also said that in bankruptcies, protection against lawsuits has a price.

"You get a discharge when you put all your assets on the table," she said. "The Sacklers didn't come anywhere close to doing that."

Arguments lasted nearly two hours in a packed courtroom, its doors draped in black in memoriam to retired Justice Sandra Day O'Connor, who died Friday. Chief Justice John Roberts offered a remembrance of the first woman to serve on the court. "She changed the world," Roberts said.

Outside the court, a small but vocal group of protesters opposed the Purdue Pharma agreement. "Shame on Sackler," one banner read. "No Sackler immunity at any $$," read another.

The issue for the justices is whether the legal shield that bankruptcy provides can be extended to people such as the Sacklers, who have not declared bankruptcy themselves. Lower courts have issued conflicting decisions over that issue, which also has implications for other major product liability lawsuits settled through the bankruptcy system.

The U.S. Bankruptcy Trustee, an arm of the Justice Department, contends that the bankruptcy law does not permit protecting the Sackler family from being sued. During the Trump administration, the government supported the settlement.

Justice Department lawyer Curtis Gannon told the court Monday that negotiations could resume, and perhaps lead to a better deal, if the court were to stop the current agreement.

Proponents of the plan said third-party releases are sometimes necessary to forge an agreement, and federal law imposes no prohibition against them.

"Forget a better deal," lawyer Pratik Shah, representing victims and other creditors in the bankruptcy, told the justices. "There is no other deal."

Lawyers for more than 60,000 victims who support the settlement called it "a watershed moment in the opioid crisis," while recognizing that "no amount of money could fully compensate" victims for the damage caused by the misleading marketing of OxyContin, a powerful prescription painkiller.

A lawyer for a victim who opposes the settlement calls the provision dealing with the Sacklers "special protection for billionaires."

Justice Ketanji Brown Jackson seemed more inclined toward the opponents, saying the Sacklers' insistence on a shield against all lawsuits is "causing this problem."

By contrast, Justice Brett Kavanaugh sounded like a vote to allow the deal to proceed. He said the government was seeking to prevent payment to victims and their families, as well as money for prevention programs "in exchange really for this somewhat theoretical idea that they'll be able to recover money down the road from the Sacklers themselves."

OxyContin first hit the market in 1996, and Purdue Pharma's aggressive marketing of it is often cited as a catalyst of the nationwide opioid epidemic, persuading doctors to prescribe painkillers with less regard for addiction dangers.

The drug and the Stamford, Connecticut-based company became synonymous with the crisis, even though the majority of pills being prescribed and used were generic drugs. Opioid-related overdose deaths have continued to climb, hitting 80,000 in recent years. Most of those are from fentanyl and other synthetic drugs.

The Purdue Pharma settlement would be among the largest reached by drug companies, wholesalers and pharmacies to resolve epidemic-related lawsuits filed by state, local and Native American tribal governments and others. Those settlements have totaled more than US$50 billion.

But the Purdue Pharma settlement would be one of only two so far that include direct payments to victims from a US$750 million pool. Payouts are expected to range from about US$3,500 to US$48,000.

Sackler family members no longer are on the company's board, and they have not received payouts from it since before Purdue Pharma entered bankruptcy. In the decade before that, though, they were paid more than US$10 billion, about half of which family members said went to pay taxes.

A decision in Harrington v. Purdue Pharma, 22-859, is expected by early summer.

CTVNews.ca Top Stories

Days after a political sign was erected outside Chip Wilson's Vancouver mansion, the waterfront property has been vandalized with graffiti.

Two people are in hospital after they were chased and shot at in what appears to be an act of road rage before eventually flipping their car while trying to escape, police say.

A disgraced Winnipeg high school football coach convicted of sexual assault and luring will spend 20 years behind bars.

The day after a minivan was set ablaze outside Vancouver City Hall, a 78-year-old man has been criminally charged.

Local Spotlight

A unique form of clouds made an appearance over the skies of Ottawa on Sunday evening.

Bernie Hicks, known as the 鈥楤atman of Amherst,鈥 always wanted to sit in a Batmobile until a kind stranger made it happen.

Bubi鈥檚 Awesome Eats, located on University Ave West took to social media to announce the closure on Friday.

Weeneebayko Area Health Authority and the Government of Ontario have awarded a $1.8 billion fixed-price contract to design, build and finance a new Far North hospital.

Manitobans are in cleanup mode after intense winds barreled through southern parts of the province this weekend.

Avry Wortman, 13, scored two touchdowns on Sunday during her team's win in the under 14 Greater Moncton Football Association.

A gargantuan gourd 鈥 affectionately named 鈥極rangina鈥 by the urban gardeners who grew it in the front yard of their Vancouver home 鈥 earned the massive honour of being named B.C.鈥檚 heaviest giant pumpkin Saturday.

Chantal Kreviazuk is set to return to Winnipeg to mark a major milestone in her illustrious musical career.

From the beaches of Cannes to the bustling streets of New York City, a new film by a trio of Manitoba directors has toured the international film festival circuit to much pomp and circumstance.